Multiple system atrophy in Hokkaido, Japan: a prospective registry study of natural history and symptom assessment scales followed for 5 years

OBJECTIVES: Multiple system atrophy (MSA) is a refractory neurodegenerative disease, but novel treatments are anticipated. An accurate natural history of MSA is important for clinical trials, but is insufficient. This regional registry was launched to complement clinical information on MSA. SETTING:...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsushima, Masaaki, Yabe, Ichiro, Sakushima, Ken, Kanatani, Yasuhiro, Nishimoto, Naoki, Matsuoka, Takeshi, Sawada, Jun, Uesugi, Haruo, Sako, Kazuya, Takei, Asako, Tamakoshi, Akiko, Shimohama, Shun, Sato, Norihiro, Kikuchi, Seiji, Sasaki, Hidenao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871682/
https://www.ncbi.nlm.nih.gov/pubmed/33558361
http://dx.doi.org/10.1136/bmjopen-2020-045100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871682/
https://www.ncbi.nlm.nih.gov/pubmed/33558361
http://dx.doi.org/10.1136/bmjopen-2020-045100

Ejemplares similares